Anchor sequence-dependent endogenous processing of human immunodeficiency virus 1 envelope glycoprotein gp160 for CD4+ T cell recognition. 1990

M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, Maryland 21205.

Human CD4+ T cell clones and cell lines were shown to lyse recombinant vaccinia virus-infected cells that synthesize the HIV-1 envelope glycoprotein gp160. The processing of endogenously synthesized gp160 for recognition by CD4+ T cells required that the protein, after synthesis on the rough endoplasmic reticulum and during subsequent cellular transport, remain attached to the luminal/extracellular membrane face by a hydrophobic anchor sequence.

UI MeSH Term Description Entries
D011498 Protein Precursors Precursors, Protein
D006678 HIV Human immunodeficiency virus. A non-taxonomic and historical term referring to any of two species, specifically HIV-1 and/or HIV-2. Prior to 1986, this was called human T-lymphotropic virus type III/lymphadenopathy-associated virus (HTLV-III/LAV). From 1986-1990, it was an official species called HIV. Since 1991, HIV was no longer considered an official species name; the two species were designated HIV-1 and HIV-2. AIDS Virus,HTLV-III,Human Immunodeficiency Viruses,Human T-Cell Lymphotropic Virus Type III,Human T-Lymphotropic Virus Type III,LAV-HTLV-III,Lymphadenopathy-Associated Virus,Acquired Immune Deficiency Syndrome Virus,Acquired Immunodeficiency Syndrome Virus,Human Immunodeficiency Virus,Human T Cell Lymphotropic Virus Type III,Human T Lymphotropic Virus Type III,Human T-Cell Leukemia Virus Type III,Immunodeficiency Virus, Human,Immunodeficiency Viruses, Human,Virus, Human Immunodeficiency,Viruses, Human Immunodeficiency,AIDS Viruses,Human T Cell Leukemia Virus Type III,Lymphadenopathy Associated Virus,Lymphadenopathy-Associated Viruses,Virus, AIDS,Virus, Lymphadenopathy-Associated,Viruses, AIDS,Viruses, Lymphadenopathy-Associated
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D015496 CD4-Positive T-Lymphocytes A critical subpopulation of T-lymphocytes involved in the induction of most immunological functions. The HIV virus has selective tropism for the T4 cell which expresses the CD4 phenotypic marker, a receptor for HIV. In fact, the key element in the profound immunosuppression seen in HIV infection is the depletion of this subset of T-lymphocytes. T4 Cells,T4 Lymphocytes,CD4-Positive Lymphocytes,CD4 Positive T Lymphocytes,CD4-Positive Lymphocyte,CD4-Positive T-Lymphocyte,Lymphocyte, CD4-Positive,Lymphocytes, CD4-Positive,T-Lymphocyte, CD4-Positive,T-Lymphocytes, CD4-Positive,T4 Cell,T4 Lymphocyte
D015686 Gene Products, env Retroviral proteins, often glycosylated, coded by the envelope (env) gene. They are usually synthesized as protein precursors (POLYPROTEINS) and later cleaved into the final viral envelope glycoproteins by a viral protease. env Gene Products,env Polyproteins,env Protein,env Antigens,env Glycoproteins,env Polyprotein,Antigens, env,Polyprotein, env,Polyproteins, env
D015752 Genes, env DNA sequences that form the coding region for the viral envelope (env) proteins in retroviruses. The env genes contain a cis-acting RNA target sequence for the rev protein ( HIV rev-Responsive Element,env Genes,rev-Responsive Element,env Gene,Element, HIV rev-Responsive,Element, rev-Responsive,Elements, HIV rev-Responsive,Elements, rev-Responsive,Gene, env,HIV rev Responsive Element,HIV rev-Responsive Elements,rev Responsive Element,rev-Responsive Element, HIV,rev-Responsive Elements,rev-Responsive Elements, HIV
D019302 HIV Envelope Protein gp160 An envelope protein of the human immunodeficiency virus that is encoded by the HIV env gene. It has a molecular weight of 160,000 kDa and contains numerous glycosylation sites. It serves as a precursor for both the HIV ENVELOPE PROTEIN GP120 and the HIV ENVELOPE PROTEIN GP41. Envelope Glycoprotein gp160, HIV,HTLV-III gp160,env Protein gp160, HIV,gp160(HIV),HIV Envelope Glycoprotein gp160,gp160 Envelope Glycoprotein, HIV,HTLV III gp160,gp160, HTLV-III
D021382 Protein Sorting Signals Amino acid sequences found in transported proteins that selectively guide the distribution of the proteins to specific cellular compartments. Leader Signal Peptides,Leader Peptide,Leader Sequences, Peptide,Peptide Leader Sequences,Peptide Signal Sequences,Signal Peptide,Signal Peptides,Signal Sequence, Peptide,Signal Sequences,Signal Sequences, Peptide,Leader Peptides,Leader Sequence, Peptide,Leader Signal Peptide,Peptide Leader Sequence,Peptide Signal Sequence,Peptide, Leader,Peptide, Leader Signal,Peptide, Signal,Peptides, Leader,Peptides, Leader Signal,Peptides, Signal,Protein Sorting Signal,Sequence, Peptide Leader,Sequence, Peptide Signal,Sequence, Signal,Sequences, Peptide Leader,Sequences, Peptide Signal,Sequences, Signal,Signal Peptide, Leader,Signal Peptides, Leader,Signal Sequence,Signal, Protein Sorting,Signals, Protein Sorting,Sorting Signal, Protein,Sorting Signals, Protein

Related Publications

M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
November 1995, Journal of virology,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
November 1989, Journal of virology,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
December 1988, Proceedings of the National Academy of Sciences of the United States of America,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
September 1991, Virology,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
November 1991, Journal of virology,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
July 1994, Blood,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
June 1994, Journal of clinical microbiology,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
November 1988, The Journal of cell biology,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
June 1993, The Journal of biological chemistry,
M Polydefkis, and S Koenig, and C Flexner, and E Obah, and K Gebo, and S Chakrabarti, and P L Earl, and B Moss, and R F Siliciano
March 1996, The Biochemical journal,
Copied contents to your clipboard!